About Diagast
Diagast is a company based in Loos (France) founded in 1988. Diagast has completed 1 acquisition, including ABO Diag SAS. Diagast offers products and services including ABD PAD®, QWALYS® 3 EVO, and ABTest Card®. Diagast operates in a competitive market with competitors including Aethon, HORIBA, Quotient Biodiagnostics, Entia and Hamilton Company, among others.
- Headquarter Loos, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$974.27 K (USD), Grant
Jun 08, 2021
-
Investors
Groupe IRD
& 2 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Diagast
Diagast offers a comprehensive portfolio of products and services, including ABD PAD®, QWALYS® 3 EVO, and ABTest Card®.
Confirms blood group for transfusion safety and accuracy.
Automates tests for efficient immuno-hematology diagnostics.
Ensures ultimate pre-transfusion blood compatibility checks.
People of Diagast
Unlock access to complete
Funding Insights of Diagast
Investors in Diagast
Diagast has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Groupe IRD, Ministry of Economy, Finance and Industrial and Digital Sovereignty and GEI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment support is provided to SMEs in Grand-Est region.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Operations across multiple industries are managed by the diversified conglomerate.
|
Locked | Locked | Locked |
Investor details for Diagast
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Diagast
Diagast has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ABO Diag SAS.
Investment portfolio details for Diagast
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of blood analyzers
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for Diagast
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Diagast
Detailed financials for Diagast
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Diagast Comparisons
Peer comparison for Diagast
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Diagast
Diagast operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aethon, HORIBA, Quotient Biodiagnostics, Entia and Hamilton Company, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Autonomous robots are deployed for hospital internal logistics and deliveries.
|
|
| Locked | Locked | Locked |
Multinational conglomerate
|
|
| Locked | Locked | Locked |
Manufacturer of immunohematology products for use in transfusion diagnostics
|
|
| Locked | Locked | Locked |
Point-of-care devices for blood analysis are developed and provided.
|
|
| Locked | Locked | Locked |
Developer of automated liquid handling systems
|
|
| Locked | Locked | Locked |
Provider of automated analyzer systems, data management software, and solutions for IVD sample preparation
|
Detailed competitors of Diagast
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Diagast
Complete news archive for Diagast
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diagast
Diagast was founded in 1988 and raised its 1st funding round 29 years after it was founded.
Diagast is headquartered in Loos, France. It is registered at Loos, Nord, France.
Diagast was founded in 1988 in Loos, France, where operations focus on the blood transfusion sector. Automated systems such as the QWALYS range and associated reagents for blood grouping are manufactured and distributed. The portfolio encompasses ABD PAD for manual grouping via M-TRAP technology, fully automated immunohematology platforms, and E.M. Technology for antibody screening, grouping, and phenotyping. Single-use plates and OEM services are also supplied to support sector needs.
Diagast's top competitors include Aethon, HORIBA and Quotient Biodiagnostics.
Diagast offers ABD PAD®, QWALYS® 3 EVO, and ABTest Card®.
Diagast has made 1 acquisition, including ABO Diag SAS.
Diagast has 3 investors. Key investors include Groupe IRD, Ministry of Economy, Finance and Industrial and Digital Sovereignty, and GEI.